A Patient Experience
A man with Lyme disease described persistent eye pain and pressure despite repeated normal eye exams. He worried that something serious was being missed, yet ophthalmologic evaluations and imaging were reassuring. The pain fluctuated and worsened with fatigue and stress. Over time, the eye pain gradually improved.
This pattern is one I see frequently in Lyme disease and other post-infectious conditions. In many patients, this type of eye pain reflects a broader pattern of autonomic and neurologic dysregulation associated with Lyme disease.
In simple terms, the eyes can hurt even when nothing looks wrong because the nerves that carry pain signals become overly sensitive. The problem is not damage to the eye, but how the nervous system is processing sensation.
Eye Pain in Lyme Disease With Normal Eye Exams
Eye pain in Lyme disease is a common but often misunderstood symptom. Patients may describe aching, pressure, stabbing discomfort, or pain behind the eyes, yet ophthalmologic exams, imaging, and vision testing are frequently normal. This disconnect can be confusing for patients and frustrating for clinicians.
A normal eye exam is reassuring because it rules out dangerous eye conditions. However, it does not rule out neurologic, autonomic, or post-infectious mechanisms that can produce very real pain. When eye exams and imaging are normal, this type of pain is rarely a sign of structural eye damage or vision-threatening disease. Patients may describe this as eye strain, eye pressure, or pain behind the eyes rather than sharp eye pain.
Sensory Nerve Involvement in Lyme Disease
The eyes and surrounding structures are richly innervated by sensory branches of the trigeminal nerve. In Lyme disease, immune activation and inflammation can sensitize these nerves, altering how pain signals are transmitted to the brain.
When sensory nerves become hypersensitive, patients may experience eye pain even in the absence of visible injury or structural abnormality. Pain may worsen with eye movement, mental effort, or light exposure. This reflects altered nerve signaling, not damage to the eye itself.
Central Sensitization and Pain Amplification
In some patients with Lyme disease, prolonged illness or repeated inflammatory flares lead to changes in how the brain processes pain. This phenomenon, known as central sensitization, causes the nervous system to amplify sensory input.
Once sensitization develops, normal sensory signals around the eyes may be perceived as painful or overwhelming. This process is biologic and neurologic in nature and does not imply that symptoms are imagined or psychological.
Autonomic Nervous System Dysregulation
The autonomic nervous system plays a role in regulating blood flow, pressure sensation, and sensory integration around the eyes. Dysautonomia is well described in Lyme disease and other post-infectious states.
Autonomic dysregulation can produce sensations of pressure, fullness, or discomfort behind the eyes. Patients often notice symptoms worsen with standing, fatigue, dehydration, or stress — patterns that point toward nervous system involvement rather than ocular disease.
Migraine Pathways in Lyme Disease
Migraines do not always present as classic throbbing head pain. In Lyme disease, migraine-like pathways may produce eye-centered pain, pressure, or light sensitivity even when headaches are minimal or absent.
When eye pain responds poorly to eye-directed treatments but fluctuates with sleep, stress, or sensory overload, a neurologic mechanism should be considered. Migraine pathways, autonomic dysfunction, and central sensitization overlap in Lyme disease.
Post-Infectious and Immune-Mediated Mechanisms
After infection, the nervous system may remain in a heightened state of reactivity. In Lyme disease, ongoing immune signaling or residual inflammation can keep sensory pathways sensitized even after initial treatment.
In clinical practice, some patients report improvement in eye pain as their overall condition stabilizes, while others experience a slower post-infectious recovery. Not all patients improve at the same pace.
Why Reassurance Alone Isn’t Enough
Being told that eye exams are normal can feel dismissive when pain persists. Eye pain without visible disease is not imagined. It reflects real changes in how the nervous system processes sensory input.
Understanding the mechanism restores trust and supports more thoughtful evaluation and care.
Frequently Asked Questions
Is eye pain in Lyme disease dangerous?
Eye pain is usually not dangerous when eye exams are normal. However, new vision loss, rapidly worsening pain, or focal neurologic symptoms should prompt further evaluation.
Is this an eye disease?
Not usually. In Lyme disease, eye pain most often reflects nerve sensitivity, migraine pathways, or autonomic dysregulation rather than a problem within the eye itself.
Can eye pain improve over time?
In some patients, eye pain improves gradually as nervous system sensitivity decreases. Recovery timelines vary.
Clinical Takeaway
Eye pain despite normal eye exams is a well-recognized manifestation of Lyme disease. It most often reflects neurologic, autonomic, or post-infectious mechanisms rather than structural eye disease. Recognizing this pattern helps prevent unnecessary testing, validates patient experience, and supports more effective care.
Selected Clinical References
Journal of Neuropsychiatry and Clinical Neurosciences Fallon BA, Levin ES, Schweitzer PJ, Hardesty D. The neuropsychiatric manifestations of Lyme borreliosis. 2008;20(2):123–135.
Frontiers in Neurology Adler BL, Vernino S. Dysautonomia following Lyme disease: a key component of post-treatment Lyme disease syndrome? 2024;15:1344862.
Pain Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. 2011;152(3 Suppl):S2–S15.
Lancet Neurology Tracey I, Mantyh PW. The cerebral signature for pain perception and its modulation. 2007;6(4):377–391.
Autonomic Neuroscience Vernino S, Bourne KM, Stiles LE, Grubb BP, Fedorowski A, Stewart JM, et al. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 NIH expert consensus meeting. 2021;235:102828.
For more:
Madison Area Lyme Support Group 